The pace at which they’re conducting these trials is a delight: they’re not rushing and they’ve not knee-jerked and changed tact along the way to pander to investors who unrealistically expect a quick return.
I remain a very happy long term holder.
GLTAH.
Ann: Trial data confirms early ischaemia detection capabilities, page-4
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
-0.005(0.26%) |
Mkt cap ! $164.4M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.94 | $1.90 | $32.16K | 16.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2617 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.94 | 5790 | 2 |
View Market Depth
| Last trade - 15.51pm 15/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |